Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 13901 - 13925 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species ▲ Gene ID Gene Symbol FlyGlycoDB Evidence References
DOID:10763 hypertension RGD:3000 Rattus norvegicus (Norway rat) 25608 Lep direct assay evidence used in manual assertion
  • PMID:20059648
DOID:4079 heart valve disease RGD:61801 Rattus norvegicus (Norway rat) 29581 Htr2b direct assay evidence used in manual assertion
  • PMID:19346455
DOID:5844 myocardial infarction RGD:69062 Rattus norvegicus (Norway rat) 83571 Cdkn1b mutant phenotype evidence used in manual assertion
  • PMID:22492676
DOID:14221 abdominal obesity-metabolic syndrome 1 RGD:3017 Rattus norvegicus (Norway rat) 24539 Lpl direct assay evidence used in manual assertion
  • PMID:26996629
DOID:11832 visual epilepsy RGD:3283 Rattus norvegicus (Norway rat) 24628 Pdgfb mutant phenotype evidence used in manual assertion
  • PMID:14980813
DOID:5082 liver cirrhosis RGD:619868 Rattus norvegicus (Norway rat) 25283 Gclc mutant phenotype evidence used in manual assertion
  • PMID:22942279
DOID:11832 visual epilepsy RGD:620630 Rattus norvegicus (Norway rat) 85268 Hrh3 direct assay evidence used in manual assertion
  • PMID:15319804
DOID:6000 congestive heart failure RGD:619850 Rattus norvegicus (Norway rat) 94203 Pgf direct assay evidence used in manual assertion
  • PMID:19327525
DOID:0060001 withdrawal disorder RGD:3435 Rattus norvegicus (Norway rat) 24929 Ptger3 mutant phenotype evidence used in manual assertion
  • PMID:10708732
DOID:224 transient cerebral ischemia RGD:621320 Rattus norvegicus (Norway rat) 81687 Mmp9 direct assay evidence used in manual assertion
  • PMID:11592852
DOID:0060108 brain glioma RGD:619831 Rattus norvegicus (Norway rat) 246097 Fas direct assay evidence used in manual assertion
  • PMID:29324390
DOID:9975 cocaine dependence RGD:61862 Rattus norvegicus (Norway rat) 29627 Gria2 mutant phenotype evidence used in manual assertion
  • PMID:20555310
DOID:614 lymphopenia RGD:2299 Rattus norvegicus (Norway rat) 25660 Cd28 mutant phenotype evidence used in manual assertion
  • PMID:12750179
DOID:4780 anti-basement membrane glomerulonephritis RGD:708418 Rattus norvegicus (Norway rat) 84349 Cd40lg mutant phenotype evidence used in manual assertion
  • PMID:15458437
DOID:11446 sciatic neuropathy RGD:2069 Rattus norvegicus (Norway rat) 24179 Agt direct assay evidence used in manual assertion
  • PMID:20886512
DOID:3525 middle cerebral artery infarction RGD:2493 Rattus norvegicus (Norway rat) 24310 Ace mutant phenotype evidence used in manual assertion
  • PMID:24471927
DOID:3770 pulmonary fibrosis RGD:620360 Rattus norvegicus (Norway rat) 83619 Nfe2l2 direct assay evidence used in manual assertion
  • PMID:19138753
DOID:11446 sciatic neuropathy RGD:2202 Rattus norvegicus (Norway rat) 24225 Bdnf direct assay evidence used in manual assertion
  • PMID:24388817
DOID:10247 pleurisy RGD:620349 Rattus norvegicus (Norway rat) 29527 Ptgs2 direct assay evidence used in manual assertion
  • PMID:20141620
DOID:6000 congestive heart failure RGD:3346 Rattus norvegicus (Norway rat) 24655 Plcd1 direct assay evidence used in manual assertion
  • PMID:11181012
DOID:7998 hyperthyroidism RGD:620330 Rattus norvegicus (Norway rat) 170587 Cs direct assay evidence used in manual assertion
  • PMID:15817832
DOID:11832 visual epilepsy RGD:620360 Rattus norvegicus (Norway rat) 83619 Nfe2l2 direct assay evidence used in manual assertion
  • PMID:24333359
DOID:6432 pulmonary hypertension RGD:621057 Rattus norvegicus (Norway rat) 116640 Tnc direct assay evidence used in manual assertion
  • PMID:15879421
DOID:5844 myocardial infarction RGD:70982 Rattus norvegicus (Norway rat) 84027 Gsk3b mutant phenotype evidence used in manual assertion
  • PMID:16565311
DOID:2560 morphine dependence RGD:620218 Rattus norvegicus (Norway rat) 81646 Creb1 direct assay evidence used in manual assertion
  • PMID:19052216
  • PMID:27053349
  • PMID:29024786
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025